ConvaTec Group (OTCMKTS:CNVVY) Shares Up 0.2% – Still a Buy?

ConvaTec Group PLC (OTCMKTS:CNVVY)’s stock price traded up 0.2% on Monday . The stock traded as high as $12.74 and last traded at $12.51. 64,086 shares were traded during trading, a decline of 44% from the average session volume of 113,734 shares. The stock had previously closed at $12.49.

Analyst Ratings Changes

Separately, Sanford C. Bernstein raised ConvaTec Group to a “strong-buy” rating in a report on Wednesday, January 28th. Two investment analysts have rated the stock with a Strong Buy rating, According to MarketBeat, the stock presently has a consensus rating of “Strong Buy”.

ConvaTec Group Stock Up 0.2%

The company’s 50 day moving average is $12.76 and its 200-day moving average is $12.74.

ConvaTec Group Company Profile

ConvaTec Group is a global medical products and technologies company focused on developing therapies and technologies for the management of chronic health conditions. The company’s portfolio spans four core business areas—Advanced Wound Care, Ostomy Care, Continence & Critical Care, and Infusion Devices—which are designed to improve patient outcomes and enhance quality of life for people living with long-term health challenges. ConvaTec’s product range includes proprietary wound dressings, ostomy and continence management systems, and safety-engineered infusion sets.

Headquartered in Reading, United Kingdom, ConvaTec serves customers in over 100 countries through a network of manufacturing, distribution, and customer support operations.